Skip to main content
SpringerLink
Log in

Antipsychotic-related impulse control disorders

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fusaroli M, et al. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment through the FDA Adverse Event Reporting System International Journal of Neuropsychopharmacology : 7 Jun 2022. Available from: URL: https://doi.org/10.1093/ijnp/pyac031

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antipsychotic-related impulse control disorders. Reactions Weekly 1910, 6 (2022). https://doi.org/10.1007/s40278-022-16841-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16841-1

Search

Navigation